1-AM

• Description:

  A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  510.998

• Molecular Formula:

  C26H28ClFN6O2

• Notes:

  Research use only, not for human use.

• Receptor:

  Ras